Pharmaceuticals
Where patents define the path from lab to market
In the pharmaceutical industry, intellectual property is inseparable from innovation. With long development cycles, heavy regulation, and limited data exclusivity, patents are often the decisive factor in securing return on investment.
We understand how patent strategy interacts with regulatory frameworks, pricing, and launch timing. Our team is experienced in helping pharma clients protect high-value molecules and formulations, not just in court, but across the entire product lifecycle.
Our Work in Pharma
We have deep experience in pharmaceutical patent enforcement and litigation, covering all procedural stages, from warning letters to full trials and settlement negotiations.
Our work includes market entry risk assessments and patent-based commercial restrictions. We also assist clients with dispute-triggered licensing and multi-jurisdictional strategy coordination.
With extensive experience in Turkish court practice and a strong grasp of regulatory and commercial dynamics, we support clients across the full lifecycle of pharmaceutical patent enforcement.
All IP prosecution
drafting, and negotiating of IP license agreements, and other contracts
Patent infringement actions, invalidity actions, actions for actions for declaration of non-infringement, Oppositions, post-grant oppositions, responses to the Patent Office actions.
Our team
Deriş Patent Building Kabataş, İstanbul
+90 212 252 6122
© 2025 Deriş. All rights reserved.
© Madde22. All rights reserved